Canada's Drug Agency | Homepage

We are Canada's Drug Agency

Learn more

Canada’s Drug Agency Launches Consultation on Methods Guide

Read more about Canada’s Drug Agency Launches Consultation on Methods Guide

Canada’s Drug Agency Announces Recipients of Funding to Enhance Rare Disease Registries

Read more about Canada’s Drug Agency Announces Recipients of Funding to Enhance Rare Disease Registries

New Flexible Service Through Our Scientific Advice Program

Read more about New Flexible Service Through Our Scientific Advice Program

Featured Reports

All Reports
All Reports

Powering evidence-informed drug and health technology decisions for sustainable, world-class health care for all

We are experts at finding, interpreting, and assembling the best available information, and we know that evidence is the foundation of good decision-making.

Learn More

A National Capital Region’s top employer

We are proud and excited to share that our organization has been named one of the National Capital Region's top employers for 2024.

Read More

Latest News

All News

Canada’s Drug Agency Receives Letter From Health Minister Regarding Pharmacare

Canada’s Drug Agency has received a letter from The Honourable Mark Holland that outlines our time-limited work related to An Act respecting ...

Canada’s Drug Agency Welcomes First Patient Member to Board of Directors

Canada’s Drug Agency is proud to welcome Maureen Smith as the first-ever Patient Member on our Board of Directors. Maureen is a respected leader in ...

Organizations Unite to Improve the Appropriate Use of Medications in Canada

A new coalition, announced today, unites 11 organizations that are working collectively to improve the appropriate prescribing and use of medications ...

Canada’s Drug Agency Launches Consultation on Methods Guide

Current consultation status: Open  Consultation period: November 28 to January 28, 2025 Canada’s Drug Agency is launching a consultation on our first ...

A Roadmap for Patient and Disease Registries: Linking Health Data to Enhance Rare Disease Decision-Making

Canada’s Drug Agency, with support from our health system partners including ICES and Health Data Research Network Canada (HDRN), has published a new ...

Canada’s Drug Agency Announces Recipients of Funding to Enhance Rare Disease Registries

Canada’s Drug Agency is pleased to announce the successful applicants from our 2024 Request for Proposals (RFP) to support the enhancement of rare ...
All News

Canada’s Drug Agency

Canada’s Drug Agency is a pan-Canadian health organization.

Created and funded by Canada’s federal, provincial, and territorial governments, we’re responsible for driving better coordination, alignment, and public value within Canada’s drug and health technology landscape.

We provide Canada’s health system leaders with independent evidence and advice so they can make informed drug, health technology, and health system decisions, and we collaborate with national and international partners to enhance our collective impact. 

Upcoming Events

All Events

Health Economics: Demystifying the Myths and Unlocking Its Value

1:00 pm - 2:00 pm
Read More Health Economics: Demystifying the Myths and Unlocking Its Value

Town Hall on Appropriate Use Strategy

1:00 to 2:00 p.m. ET
Read More Town Hall on Appropriate Use Strategy
All Events
postcard

Canada’s Drug Agency recognizes the traditional territories, rights, and diversity of all First Nations, Inuit, and Métis communities across Canada. Indigenous Peoples have been, and continue to be, excluded from and harmed by Canada’s health care systems. In the spirit of reconciliation, we are committed to addressing these inequities alongside Indigenous communities.